Withdrawn

A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer

JECD - ClinicalTrials.gov - NCT04158700

The main purpose of this study is to see if the drug LY3200882 which is an inhibitor of transforming growth factor-β (TGFβ) receptor 1 in combination with pembrolizumab is safe and effective in participants with cancer that has spread to other parts of the body.
How long will I be in the trial?
Your participation in this trial could last up to 24 months, depending on how you and your tumor respond.
Email
Withdrawn

A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer

JECD - ClinicalTrials.gov - NCT04158700

The main purpose of this study is to see if the drug LY3200882 which is an inhibitor of transforming growth factor-β (TGFβ) receptor 1 in combination with pembrolizumab is safe and effective in participants with cancer that has spread to other parts of the body.
How long will I be in the trial?
Your participation in this trial could last up to 24 months, depending on how you and your tumor respond.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Advanced Cancer

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

130

Trial Dates

December 2019 - May 2023

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Advanced Cancer

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

130

Trial Dates

December 2019 - May 2023

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Advanced Cancer Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?